Saw Palmetto + Nettle (Combo) for Urinary Tract Health

Research suggests that the combination of saw palmetto (Serenoa repens) and stinging nettle root (Urtica dioica), most commonly studied as the fixed-dose preparation PRO 160/120 or WS 1541, is associated with meaningful improvements in lower urinary tract symptoms related to benign prostatic hyperplasia, including reduced nighttime urination, improved urinary flow rate, and lower symptom scores on standardized measures such as the IPSS. The evidence base includes multiple randomized controlled trials, at least one meta-analysis, several narrative reviews, and preclinical studies in cell and animal models, with the large majority pointing in a supportive direction; one 2000 clinical trial found the combination comparable to the prescription drug finasteride for improving maximum urinary flow, and a 2015 study found the combination outperformed saw palmetto used alone. One mixed-direction review noted that saw palmetto as a monotherapy has not consistently outperformed placebo, suggesting the nettle root component may contribute meaningfully to the combination's observed effects. Limitations across the evidence base include variability in study duration, patient populations, and product formulations, and a 2000 meta-analysis cautioned that longer and better-designed trials are needed before broad clinical recommendations can be made, so readers are encouraged to consult a qualified healthcare provider before drawing personal conclusions.